Korst AE - Search Results

1

The radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro.

Pauwels B, Korst AE, de Pooter CM, Lambrechts HA, Pattyn GG, Lardon F, Vermorken JB. Pauwels B, et al. Among authors: korst ae. Eur J Cancer. 2003 Apr;39(6):838-46. doi: 10.1016/s0959-8049(03)00002-9. Eur J Cancer. 2003. PMID: 12651211

2

Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies.

Pauwels B, Korst AE, de Pooter CM, Pattyn GG, Lambrechts HA, Baay MF, Lardon F, Vermorken JB. Pauwels B, et al. Among authors: korst ae. Cancer Chemother Pharmacol. 2003 Mar;51(3):221-6. doi: 10.1007/s00280-002-0557-9. Epub 2003 Jan 22. Cancer Chemother Pharmacol. 2003. PMID: 12655440

3

Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro.

Pauwels B, Korst AE, Pattyn GG, Lambrechts HA, Van Bockstaele DR, Vermeulen K, Lenjou M, de Pooter CM, Vermorken JB, Lardon F. Pauwels B, et al. Among authors: korst ae. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1075-83. doi: 10.1016/s0360-3016(03)01443-3. Int J Radiat Oncol Biol Phys. 2003. PMID: 14575839

4

Combined modality therapy of gemcitabine and radiation.

Pauwels B, Korst AE, Lardon F, Vermorken JB. Pauwels B, et al. Among authors: korst ae. Oncologist. 2005 Jan;10(1):34-51. doi: 10.1634/theoncologist.10-1-34. Oncologist. 2005. PMID: 15632251 Free article. Review.

5

Unraveling the mechanism of radiosensitization by gemcitabine: the role of TP53.

Pauwels B, Korst AE, Andriessen V, Baay MF, Pattyn GG, Lambrechts HA, Pooter CM, Lardon F, Vermorken JB. Pauwels B, et al. Among authors: korst ae. Radiat Res. 2005 Nov;164(5):642-50. doi: 10.1667/rr3445.1. Radiat Res. 2005. PMID: 16238441

6

Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro.

Simoens C, Vermorken JB, Korst AE, Pauwels B, De Pooter CM, Pattyn GG, Lambrechts HA, Breillout F, Lardon F. Simoens C, et al. Among authors: korst ae. Cancer Chemother Pharmacol. 2006 Aug;58(2):210-8. doi: 10.1007/s00280-005-0147-8. Epub 2005 Nov 30. Cancer Chemother Pharmacol. 2006. PMID: 16317558

7

The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro.

Pauwels B, Korst AE, Lambrechts HA, Pattyn GG, de Pooter CM, Lardon F, Vermorken JB. Pauwels B, et al. Among authors: korst ae. Cancer Chemother Pharmacol. 2006 Aug;58(2):219-28. doi: 10.1007/s00280-005-0158-5. Epub 2005 Dec 6. Cancer Chemother Pharmacol. 2006. PMID: 16331496

8

The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines.

Pauwels B, Korst AE, Pattyn GG, Lambrechts HA, Kamphuis JA, De Pooter CM, Peters GJ, Lardon F, Vermorken JB. Pauwels B, et al. Among authors: korst ae. BMC Cancer. 2006 May 30;6:142. doi: 10.1186/1471-2407-6-142. BMC Cancer. 2006. PMID: 16734894 Free PMC article.

9

In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects.

Simoens C, Korst AE, De Pooter CM, Lambrechts HA, Pattyn GG, Faircloth GT, Lardon F, Vermorken JB. Simoens C, et al. Among authors: korst ae. Br J Cancer. 2003 Dec 15;89(12):2305-11. doi: 10.1038/sj.bjc.6601431. Br J Cancer. 2003. PMID: 14676811 Free PMC article.

10

Pharmacokinetics of amifostine and its metabolites in patients.

Korst AE, Eeltink CM, Vermorken JB, van der Vijgh WJ. Korst AE, et al. Eur J Cancer. 1997 Aug;33(9):1425-9. doi: 10.1016/s0959-8049(97)00138-x. Eur J Cancer. 1997. PMID: 9337685 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters